Publications / Presentations

• 09/21/2018 | Synedgen’s Senior Scientist Publishes New Research

  Study sheds light on S. aureus virulence factor regulation Claremont Calif. — September 21, 2018 — Research conducted by Synedgen Inc.’s Senior Scientist and colleagues from the University of Arkansas […] More

• 05/20/2016 | Synedgen to Present New Treatment Options for Gastrointestinal Radiation Injury

  Innovative Treatment to Reduce Cancer Therapy Complications Radiotherapy is a well-established treatment for cancer, however pelvic radiotherapy can result in radiation proctitis, or inflammation and damage to the lower parts […] More

• 08/31/2015 | Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research

  Study suggests that anti-retroviral lectins have a modest potential for preventing or treating Trichomonas infections More

• 10/01/2014 | Synedgen to Present at North American Cystic Fibrosis Conference

  Innovative Treatment to Improve Lung Function and Antibiotic Effectiveness in CF Patients More

• 10/08/2013 | Synedgen to Report Promising Research at National Cystic Fibrosis Conference

  Potential Treatment to Improve Lung Function and Antibiotic Effectiveness in Patients with Cystic Fibrosis More

• 02/12/2013 | Synedgen President Shenda Baker Featured Presenter at the Grinnell-in-Los Angeles: Scientists Making a Difference in the World Conference

  Synedgen President Shenda Baker will be a featured presenter at the upcoming Grinnell Scientists: Making a Difference in the World Conference More

• 10/30/2012 | Synedgen Selected as Showcase Company to Present at SoCalBio Conference

  Conference highlights the strength and future of the Los Angeles area bioscience industry More